CHF 169,400.00 - CHF 314,600.00
Brings external benchmarking, analysis and insights, and judgement to support the TA Strategy Head in developing a holistic Novartis TA strategy that achieves sustainable growth in short, mid and long-term.
Brings both understanding of the pharmaceutical industry and the core Therapeutic Areas (TA) and Disease area of Oncology & Hematology to derive insightful and differentiating competitive advantages over our peers.
Provides key commercial insights to the R&D project teams, particularly for early phase programs. To do this effectively, in-market experience in the US is critical.
Analyses reports and publications to extract key messages, including building product forecasts.
Supports development and delivery of TA-specific strategic external insights to support identification of growth opportunities, emerging competitive challenges and support creation of a third-party view around key strategic levers, and commissions targeted primary research.
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
